How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Transcutaneous Bilirubin Meters Market
- By Product Type: Handheld Transcutaneous Bilirubin Meters, Desktop Transcutaneous Bilirubin Meters
- By End User: Hospitals, Clinics, Diagnostic Laboratories, Neonatal Care Centers
- By Technology: Optical Spectroscopy, Multi-Wavelength Spectroscopy, LED-Based Technology
- By Application: Neonatal Jaundice Screening, Bilirubin Level Monitoring, Newborn Health Assessment
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Handheld Transcutaneous Bilirubin Meters leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 268 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.157 →
- 11 Company Profiles 17 players: SWOT & benchmarking p.165 →
Full report · locked preview
Everything inside the Transcutaneous Bilirubin Meters Market report
A complete, evidence-based study - 11 chapters and 112 sections covering market size, segmentation across 4 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Product Type 2
End User 4
Technology 3
Application 3
Companies profiled
Drägerwerk AG & Co. KGaA
Philips Healthcare
Natus Medical Incorporated
Respironics
Inc. (a Philips company)
PeriMed AB
Draeger Medical Systems Inc.
Konica Minolta Inc.
Masimo Corporation
Welch Allyn (Hill-Rom Holdings
Inc.)
Medtronic plc
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Drägerwerk AG & Co. KGaA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Natus Medical Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Respironics
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Inc. (a Philips company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →PeriMed AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Draeger Medical Systems Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Konica Minolta Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Masimo Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Welch Allyn (Hill-Rom Holdings
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Inc.)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Medtronic plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →GE Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Nihon Kohden Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Mindray Medical International Limited
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Edan Instruments Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,033M by 2033 · 6.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Handheld Transcutaneous Bilirubin Meters86.4
- Desktop Transcutaneous Bilirubin Meters13.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$403.8M → $632.1M · 5.8%
Europe$281.5M → $436.0M · 5.6%
Asia Pacific$257.0M → $439.2M · 6.9%
Latin America$159.1M → $254.7M · 6.1%
Middle East and Africa$122.4M → $221.6M · 7.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.502026
6.522027
6.542028
6.532029
6.562030
6.552031
6.582032
6.582033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Drägerwerk AG & Co. KGaA19.9
- Philips Healthcare14.4
- Natus Medical Incorporated13.1
- Respironics5.7
- Inc. (a Philips company)11.9
- PeriMed AB6.9
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type29.3%
End User18.0%
Technology23.7%
Application29.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.9
- Europe22.0
- Asia Pacific22.1
- Latin America12.8
- Middle East and Africa11.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Drägerwerk AG & Co. KGaA | 87 | 93 | 99 | 79 | 90 | 93 | 90 |
| Philips Healthcare | 74 | 75 | 79 | 91 | 69 | 80 | 78 |
| Natus Medical Incorporated | 64 | 70 | 75 | 87 | 73 | 75 | 74 |
| Respironics | 77 | 68 | 80 | 59 | 69 | 71 | 71 |
| Inc. (a Philips company) | 71 | 54 | 61 | 70 | 75 | 57 | 65 |
| PeriMed AB | 65 | 50 | 56 | 60 | 68 | 47 | 58 |
| Draeger Medical Systems Inc. | 52 | 57 | 43 | 64 | 66 | 50 | 55 |
| Konica Minolta Inc. | 50 | 36 | 39 | 51 | 52 | 36 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Drägerwerk AG & Co. KGaA
- Philips Healthcare
- Natus Medical Incorporated
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Drägerwerk AG & Co. KGaA | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Philips Healthcare | ✓ | ◐ | ◐ | ✓ | ◐ | ✓ |
| Natus Medical Incorporated | − | ◐ | ✓ | ✓ | ◐ | ◐ |
| Respironics | ◐ | ◐ | ✓ | − | ◐ | ✓ |
| Inc. (a Philips company) | ◐ | ◐ | ◐ | − | ✓ | ◐ |
| PeriMed AB | ◐ | − | ◐ | ◐ | ◐ | − |
| Draeger Medical Systems Inc. | ◐ | − | − | ◐ | ✓ | − |
| Konica Minolta Inc. | − | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Drägerwerk AG & Co. KGaA90
2Philips Healthcare78
3Natus Medical Incorporated74
4Respironics71
5Inc. (a Philips company)65
6PeriMed AB58
7Draeger Medical Systems Inc.55
8Konica Minolta Inc.44
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Drägerwerk AG & Co. KGaAPhilips Healthcare
Challenger2
Strong scale, closing on the leaders.
Natus Medical IncorporatedRespironics
Contender2
Focused players with pockets of strength.
Inc. (a Philips company)PeriMed AB
Niche2
Specialists in a single segment or region.
Draeger Medical Systems Inc.Konica Minolta Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Transcutaneous Bilirubin Meters Market — a $364M beachhead inside a $6.13B market.
Beachhead (SOM)$364Mobtainable near-term
Serviceable (SAM)$2.56Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Handheld Transcutaneous Bilirubin Meters
Best fit — highest urgency & budget in Product Type.
Economic buyer81 fit
Desktop Transcutaneous Bilirubin Meters
Strong fit — clear ROI and a fast path to value.
End user65 fit
Enterprise buyers
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Technology
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel29%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Transcutaneous Bilirubin Meters Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified26%
Evaluation13%
Closed-won5%
$19.8KCAC
$86KLTV
4.3:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Transcutaneous Bilirubin Meters Market is a high-growth opportunity — $7.89B by 2033, compounding at 10.4%.
TAM · 2025$3.56Btoday
TAM · 2033$7.89Bforecast
CAGR10.4%2027–2033
Cumulative$49.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.89BTotal addressable market
SAM$2.94BServiceable available market
SOM$476MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.4% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.89BLarge & growingTAM by 2033 at 10.4% CAGR
$2.94BServiceable nowreachable with today’s model
$476MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.15BBear6.8% CAGR
$7.89BBase10.4% CAGR
$10.1BBull13.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Transcutaneous Bilirubin Meters Market — a $9.42B market by 2033. Plan: grow share from 5.9% to 12.0%.
Market size · 2033$9.42Btotal addressable
Market CAGR10.3%2027–2033
Target share12.0%from 5.9% today
Revenue ambition$1.13Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.9% | 12.0% | At risk |
| Revenue | $571M | $1.13B | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 35.4% | 44.0% | At risk |
| Customer retention | 88.0% | 95.5% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $115M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Transcutaneous Bilirubin Meters Market conversation — a $1.66B market you can size, segment and defend in minutes.
Market size · 2033$1.66Btotal opportunity
Growth9.1%CAGR to 2033
Addressable buyers1,270+accounts in scope
Typical ROI7.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.4×return on cost, year one
< 3 mopayback period
$44K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
Drägerwerk AG & Co. KGaAPhilips HealthcareNatus Medical IncorporatedRespironicsInc. (a Philips company)PeriMed ABDraeger Medical Systems Inc.Konica Minolta Inc.+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Transcutaneous Bilirubin Meters Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Transcutaneous Bilirubin Meters Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Transcriptome Technology Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportTranscriptome Sequencing Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportTranscriptome Sequencing Based on RNA-seq Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportTranscription Factor Analysis Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportTranscranial Ultrasound Stimulation (TUS) System Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportTranscranial Stimulator Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportTranscranial Magnetic Stimulator for Depression Requisition Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportTranscranial Magnetic Stimulation Treatment Market
Market size, share, segmentation and regional forecast.
$926M market · 2025 base year
View reportTranscranial Magnetic Stimulation Treatment Devices Market
Market size, share, segmentation and regional forecast.
$587M market · 2025 base year
View reportTranscranial Magnetic Stimulation (TMS) Service Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportTranscranial Magnetic Stimulation System Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportTranscranial Electrical Stimulation (tES) Devices Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.